{"pmid":32440978,"title":"Telemedicine and technological devices for amyotrophic lateral sclerosis in the era of COVID-19.","text":["Telemedicine and technological devices for amyotrophic lateral sclerosis in the era of COVID-19.","Neurol Sci","De Marchi, Fabiola","Cantello, Roberto","Ambrosini, Serena","Mazzini, Letizia","32440978"],"journal":"Neurol Sci","authors":["De Marchi, Fabiola","Cantello, Roberto","Ambrosini, Serena","Mazzini, Letizia"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32440978","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1007/s10072-020-04457-8","topics":["Prevention"],"weight":1,"_version_":1667523504776413184,"score":9.490897,"similar":[{"pmid":32445195,"title":"Amyotrophic Lateral Sclerosis Care and Research in the USA During the COVID-19 Pandemic: Challenges and Opportunities.","text":["Amyotrophic Lateral Sclerosis Care and Research in the USA During the COVID-19 Pandemic: Challenges and Opportunities.","COVID-19 has created unprecedented challenges for amyotrophic lateral sclerosis (ALS) clinical care and research in the United States. Traditional evaluations for making an ALS diagnosis, measuring progression, and planning interventions rely on in-person visits that may now be unsafe or impossible. Evidence- and experience-based treatment options such as multidisciplinary team care, feeding tubes, wheelchairs, home health and hospice have become more difficult to obtain and in some places are unavailable. Additionally, the pandemic has impacted ALS clinical trials by impairing the ability to obtain measurements for trial eligibility, to monitor safety and efficacy outcomes, and to dispense study drug since these also often rely on in-person visits. We review opportunities for overcoming some of these challenges through telemedicine and novel measurements. These can re-optimize ALS care and research in the current setting and during future events that may limit travel and face to face interactions. This article is protected by copyright. All rights reserved.","Muscle Nerve","Andrews, Jinsy A","Berry, James D","Baloh, Robert H","Carberry, Nathan","Cudkowicz, Merit E","Dedi, Brixhilda","Glass, Jonathan","Maragakis, Nicholas J","Miller, Timothy M","Paganoni, Sabrina","Rothstein, Jeffrey D","Shefner, Jeremy M","Simmons, Zachary","Weiss, Michael D","Bedlack, Richard S","32445195"],"abstract":["COVID-19 has created unprecedented challenges for amyotrophic lateral sclerosis (ALS) clinical care and research in the United States. Traditional evaluations for making an ALS diagnosis, measuring progression, and planning interventions rely on in-person visits that may now be unsafe or impossible. Evidence- and experience-based treatment options such as multidisciplinary team care, feeding tubes, wheelchairs, home health and hospice have become more difficult to obtain and in some places are unavailable. Additionally, the pandemic has impacted ALS clinical trials by impairing the ability to obtain measurements for trial eligibility, to monitor safety and efficacy outcomes, and to dispense study drug since these also often rely on in-person visits. We review opportunities for overcoming some of these challenges through telemedicine and novel measurements. These can re-optimize ALS care and research in the current setting and during future events that may limit travel and face to face interactions. This article is protected by copyright. All rights reserved."],"journal":"Muscle Nerve","authors":["Andrews, Jinsy A","Berry, James D","Baloh, Robert H","Carberry, Nathan","Cudkowicz, Merit E","Dedi, Brixhilda","Glass, Jonathan","Maragakis, Nicholas J","Miller, Timothy M","Paganoni, Sabrina","Rothstein, Jeffrey D","Shefner, Jeremy M","Simmons, Zachary","Weiss, Michael D","Bedlack, Richard S"],"date":"2020-05-24T11:00:00Z","year":2020,"_id":"32445195","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1002/mus.26989","keywords":["amyotrophic lateral sclerosis","covid-19","clinical care","clinical trials","pandemic"],"locations":["United States"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1667600475965358080,"score":96.01535},{"pmid":32417612,"title":"Modification of non-invasive ventilation for the advanced amyotrophic lateral sclerosis patient during the COVID-19 pandemic - do it now.","text":["Modification of non-invasive ventilation for the advanced amyotrophic lateral sclerosis patient during the COVID-19 pandemic - do it now.","J Neurol Sci","Young, Eufrosina I","Manta, Dragos","Sah, Birendra P","Brooks, Benjamin Rix","32417612"],"journal":"J Neurol Sci","authors":["Young, Eufrosina I","Manta, Dragos","Sah, Birendra P","Brooks, Benjamin Rix"],"date":"2020-05-18T11:00:00Z","year":2020,"_id":"32417612","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.jns.2020.116893","keywords":["amyotrophic lateral sclerosis","covid-19 pandemic","non-invasive ventilation"],"topics":["Prevention"],"weight":1,"_version_":1667058206839406593,"score":92.039505},{"pmid":32429702,"title":"Telemedicine Consultations and Diabetes Technology During COVID-19.","text":["Telemedicine Consultations and Diabetes Technology During COVID-19.","J Diabetes Sci Technol","Norgaard, Kirsten","32429702"],"journal":"J Diabetes Sci Technol","authors":["Norgaard, Kirsten"],"date":"2020-05-21T11:00:00Z","year":2020,"_id":"32429702","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1177/1932296820929378","keywords":["cgm","covid-19","insulin pumps","telemedicine consultations","type 1 diabetes","uploading programs"],"topics":["Prevention"],"weight":1,"_version_":1667342288160817152,"score":42.716568},{"pmid":32429770,"title":"Technology Literacy as a Barrier to Telehealth During COVID-19.","text":["Technology Literacy as a Barrier to Telehealth During COVID-19.","Telemed J E Health","Triana, Austin J","Gusdorf, Roman E","Shah, Kaustav P","Horst, Sara N","32429770"],"journal":"Telemed J E Health","authors":["Triana, Austin J","Gusdorf, Roman E","Shah, Kaustav P","Horst, Sara N"],"date":"2020-05-21T11:00:00Z","year":2020,"_id":"32429770","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1089/tmj.2020.0155","keywords":["access","health literacy","telehealth","telemedicine"],"topics":["Prevention"],"weight":1,"_version_":1667342288169205760,"score":42.716568}]}